查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
DTC（直接面向消费者）测试产业：全球市场
市场调查报告书
商品编码
1487489

DTC（直接面向消费者）测试产业：全球市场

Direct-to-Consumer Testing Industry: Global Markets
出版日期: | 出版商: BCC Research | 英文 81 Pages | 订单完成后即时交付

价格

全球DTC（直接面向消费者）测试市场规模预计将从2023年的16亿美元增加到2029年的32亿美元，预测期间内复合年增长率为12.5%。

基因 DTC 检测产业预计将从 2023 年的 13 亿美元增至 2029 年的 27 亿美元，复合年增长率为 12.7%。此外，微生物组 DTC 测试领域预计将从 2023 年的 513 亿美元增至 2029 年的 1,095 亿美元，复合年增长率为 13.7%。

该报告调查了全球DTC（直接面向消费者）测试市场，并提供了市场概况、市场影响因素和市场机会分析、新兴技术和技术发展趋势、专利趋势、市场规模趋势和预测以及各种资讯。了按细分市场和地区、竞争状况、主要企业概况等进行的详细分析。

目录

第一章执行摘要

  • 市场展望
  • 调查范围
  • 市场概况

第二章 市场概况

  • 概述
  • PESTEL分析
  • 波特五力分析
  • 产业竞争
  • 监管状况
  • 美国
  • 欧洲
  • 亚太地区
  • 其他地区

第三章市场动态

  • 市场动态
  • 市场驱动因素
  • 消费者和医生意识不断增强
  • 降低基因序列分析的成本
  • 市场限制因素
  • 缺乏监管指引
  • 结果不准确
  • 市场机会
  • 新兴经济体
  • 市场挑战
  • 道德和资料隐私问题

第四章新兴科技与发展

  • 新技术
  • 基因序列分析的进展
  • 数位化
  • AI
  • 专利分析
  • 专利：按公司划分

第五章市场区隔分析

  • 按细分市场细分
  • 市场分析：按测试类型
  • 基因DTC测试
  • 基于生物标记的 DTC 测试
  • 微生物组 DTC 测试
  • 市场分析：依应用分类
  • 健康/保健
  • 祖先/家谱
  • 疾病风险评估
  • 职业筛检
  • 药物基因学检测
  • 基于全基因组序列的DTC检测
  • 其他的
  • 市场分析：按分销管道
  • 在线的
  • 零售
  • 地域分布
  • 市场分析：按地区
  • 北美洲
  • 欧洲
  • 亚太地区
  • 其他地区

第六章 竞争讯息

  • 市场分析
  • 主要企业
  • 战略分析

第 7 章 DTC（直接面向消费者）检视的永续性：ESG 视角

  • ESG：概述
  • DTC 检视产业的永续性：ESG 视角
  • 主要 ESG 议题
  • DTC检测产业ESG绩效分析
  • BCC的结语

第8章附录

  • 调查方法
  • 来源
  • 缩写词
  • 公司简介
  • 23ANDME INC.
  • ANCESTRY
  • GENETIC TECHNOLOGIES LTD.
  • EVERLYWELL INC.
  • LABORATORY CORPORATION OF AMERICA HOLDINGS
  • MAPMYGENOME
  • MICROBIOME LABS
  • MYHERITAGE LTD.
  • QUEST DIAGNOSTICS INC.
  • VIOME LIFE SCIENCES INC.
Product Code: HLC269B

The global market for direct-to-consumer (DTC) testing is estimated to increase from $1.6 billion in 2023 to reach $3.2 billion by 2029, at a compound annual growth rate (CAGR) of 12.5% from 2024 through 2029.

The genetic DTC tests market for DTC testing is estimated to increase from $1.3 billion in 2023 to reach $2.7 billion by 2029, at a CAGR of 12.7% from 2024 through 2029.

The microbiome DTC tests market for DTC testing is estimated to increase from $51.3 billion in 2023 to reach $109.5 billion by 2029, at a CAGR of 13.7% from 2024 through 2029.

Report Scope

The current report provides detailed information about the direct-to-consumer (DTC) testing market. The report provides market projections for 2029 and market share for key market players. It details the market size of DTC testing based on test types, applications and distribution channels. Based on the test type, the DTC testing market is segmented into genetic DTC tests, biomarker-based DTC tests and microbiome DTC tests. The report excludes at-home pregnancy tests, fertility tests and COVID-19 tests. Provider-dependent at-home tests also are not included in this report. The report is segmented into health and wellness testing, ancestry and genealogy testing, carrier screening, disease risk assessment, pharmacogenetic testing, whole genome sequence-based DTC testing and other DTC tests based on application. Based on the distribution channel, the market is categorized into online and retail.

Report Includes

  • 21 data tables and 42 additional tables
  • Analysis of the global market landscape of direct-to-consumer (DTC) testing industry
  • Analyses of the global market trends, with market revenue data for 2022, estimates for 2023, forecasts for 2024, and projected CAGRs through 2029
  • Estimate of the current market size and revenue prospects, along with a market share analysis by test type, application, distribution channel and region
  • Facts and figures pertaining to the market dynamics, current and emerging technologies, regulations, and the expected impact of macroeconomic factors
  • An analysis of patents related to DTC
  • Overview of sustainability trends and ESG developments in the industry, with a focus on consumer attitudes, companies' ESG score rankings and their ESG practices
  • An analysis of the industry structure, including companies' market shares, M&A activity, and venture funding
  • Company profiles of major players within the industry, including Ancestry, 23andMe Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Inc., and MyHeritage Ltd.

Table of Contents

Chapter 1 Executive Summary

  • Market Outlook
  • Scope of Report
  • Market Summary

Chapter 2 Market Overview

  • Overview
  • PESTEL Analysis
  • Porter's 5 Forces Analysis
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Potential of New Entrants
  • Threat of Substitutes
  • Competition in the Industry
  • Regulatory Landscape
  • U.S.
  • Europe
  • Asia-Pacific
  • Rest of the World

Chapter 3 Market Dynamics

  • Market Dynamics
  • Market Drivers
  • Rising Consumer and Physician Awareness
  • Decreasing Costs of Genetic Sequencing
  • Market Restraints
  • Lack of Regulatory Guidelines
  • Inaccuracy of Results
  • Market Opportunities
  • Emerging Economies
  • Market Challenges
  • Ethical and Data Privacy Issues

Chapter 4 Emerging Technologies and Developments

  • Emerging Technologies
  • Advances in Gene Sequencing
  • Digitalization
  • Artificial Intelligence
  • Patent Analysis
  • Patents, by Company

Chapter 5 Market Segmentation Analysis

  • Segmental Breakdown
  • Market Analysis, by Test Type
  • Genetic DTC Tests
  • Biomarker-based DTC Tests
  • Microbiome DTC Tests
  • Market Breakdown, by Application
  • Health and Wellness Testing
  • Ancestry and Genealogy Testing
  • Disease Risk Assessment
  • Carrier Screening
  • Pharmacogenetic Testing
  • Whole Genome Sequence-based DTC Testing
  • Other DTC Tests
  • Market Breakdown, by Distribution Channel
  • Online Channel
  • Retail Channels
  • Geographic Breakdown
  • Market Analysis, by Region
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Chapter 6 Competitive Intelligence

  • Market Analysis
  • Top Players
  • Strategic Analysis

Chapter 7 Sustainability in Direct-to-Consumer Testing: ESG Perspective

  • Introduction to ESG
  • Sustainability in Direct-to-Consumer (DTC) Testing Industry: An ESG Perspective
  • Key ESG Issues
  • DTC Testing Industry ESG Performance Analysis
  • Concluding Remarks from BCC

Chapter 8 Appendix

  • Methodology
  • Sources
  • Acronyms
  • Company Profiles
  • 23ANDME INC.
  • ANCESTRY
  • GENETIC TECHNOLOGIES LTD.
  • EVERLYWELL INC.
  • LABORATORY CORPORATION OF AMERICA HOLDINGS
  • MAPMYGENOME
  • MICROBIOME LABS
  • MYHERITAGE LTD.
  • QUEST DIAGNOSTICS INC.
  • VIOME LIFE SCIENCES INC.

List of Tables

  • Summary Table : Global Market for DTC Testing, by Test Type, Through 2029
  • Table 1 : Comparison: DTC tests v/s Traditional Medical Tests
  • Table 2 : FDA Regulation of DTC Tests
  • Table 3 : DTC Genetic Tests: Ethical Issues
  • Table 4 : Patents, by Top Companies, 2022-2024
  • Table 5 : Global Market for DTC Testing, by Test Type, Through 2029
  • Table 6 : Global Market for Genetic DTC Tests, by Region, Through 2029
  • Table 7 : Global Market for Biomarker-based DTC Tests, by Region, Through 2029
  • Table 8 : Global Market for Microbiome DTC Tests, by Region, Through 2029
  • Table 9 : Global Market for DTC Testing, by Application, Through 2029
  • Table 10 : List of DTC Tests for Health and Wellness
  • Table 11 : Global Market for Health and Wellness DTC Testing, by Region, Through 2029
  • Table 12 : DTC Ancestry and Genealogy Tests
  • Table 13 : Global Market for Ancestry and Genealogy DTC Testing, by Region, Through 2029
  • Table 14 : Global Market for Disease Risk Assessment in DTC Testing, by Region, Through 2029
  • Table 15 : Global Market for Carrier Screening in DTC Testing, by Region, Through 2029
  • Table 16 : Global Market for Pharmacogenetic DTC Testing, by Region, Through 2029
  • Table 17 : List of WGS-based DTC Testing Companies, as of February 2022
  • Table 18 : Global Market for Whole Genome Sequence-based DTC Testing, by Region, Through 2029
  • Table 19 : Global Market for Other DTC Tests, by Region, Through 2029
  • Table 20 : Global Market for DTC Testing, by Distribution Channel, Through 2029
  • Table 21 : List of Some DTC Tests Available on Amazon
  • Table 22 : Global Market for Online Channel for DTC Testing, by Region, Through 2029
  • Table 23 : Global Market for Retail Channels for DTC Testing, by Region, Through 2029
  • Table 24 : Global Market for DTC Testing, by Region, Through 2029
  • Table 25 : DTC Testing: Market Player Share Analysis, 2023
  • Table 26 : Direct-to-Consumer Testing: Recent Developments, 2024
  • Table 27 : ESG Rankings for DTC Testing Companies, 2024*
  • Table 28 : ESG: Environmental Overview
  • Table 29 : ESG: Social Overview
  • Table 30 : ESG: Governance Overview
  • Table 31 : Report Sources
  • Table 32 : Glossary of Terms Used in Direct-to-Consumer Testing Market
  • Table 33 : 23andMe Inc.: Company Snapshot
  • Table 34 : 23andMe Inc.: Financial Performance, FY 2022 and 2023
  • Table 35 : 23andMe Inc.: Product Portfolio
  • Table 36 : 23andMe Inc.: News/Key Developments, 2021-2023
  • Table 37 : Ancestry: Company Snapshot
  • Table 38 : Ancestry: Product Portfolio
  • Table 39 : Ancestry: News/Key Developments, 2021-2023
  • Table 40 : Genetic Technologies Ltd.: Company Snapshot
  • Table 41 : Genetic Technologies Ltd.: Financial Performance, FY 2022 and 2023
  • Table 42 : Genetic Technologies Ltd.: Product Portfolio
  • Table 43 : Genetic Technologies Ltd.: News/Key Developments, 2021-2023
  • Table 44 : Everlywell Inc.: Company Snapshot
  • Table 45 : Everlywell Inc.: Product Portfolio
  • Table 46 : Laboratory Corporation of America Holdings: Company Snapshot
  • Table 47 : Laboratory Corporation of America Holdings: Financial Performance, FY 2022 and 2023
  • Table 48 : Laboratory Corporation of America Holdings: Product Portfolio
  • Table 49 : Laboratory Corporation of America Holdings: News/Key Developments, 2023
  • Table 50 : MapmyGenome: Company Snapshot
  • Table 51 : MapmyGenome: Product Portfolio
  • Table 52 : Microbiome Labs: Company Snapshot
  • Table 53 : Microbiome Labs: Product Portfolio
  • Table 54 : MyHeritage Ltd.: Company Snapshot
  • Table 55 : MyHeritage Ltd.: Product Portfolio
  • Table 56 : Quest Diagnostics Inc.: Company Snapshot
  • Table 57 : Quest Diagnostics Inc.: Financial Performance, FY 2022 and 2023
  • Table 58 : Quest Diagnostics Inc.: Product Portfolio
  • Table 59 : Quest Diagnostics Inc.: News/Key Developments, 2022-2023
  • Table 60 : Viome Life Sciences Inc.: Company Snapshot
  • Table 61 : Viome Life Sciences Inc.: Product Portfolio
  • Table 62 : Viome Life Sciences Inc.: News/Key Developments, 2022

List of Figures

  • Summary Figure : Global Market for DTC Testing, by Test Type, 2021-2029
  • Figure 1 : DTC Testing: Types
  • Figure 2 : DTC Testing: Advantages and Disadvantages
  • Figure 3 : DTC Testing: PESTEL Analysis
  • Figure 4 : Market Dynamics of DTC Testing
  • Figure 5 : Cost Per Genome, November 2017-May 2022
  • Figure 6 : Emerging Trends/Technologies in the DTC Testing Market
  • Figure 7 : Global Market Shares for DTC Testing, by Test Type, 2023
  • Figure 8 : Global Market Shares for DTC Testing, by Application, 2023
  • Figure 9 : Types of Genetic Ancestry Testing
  • Figure 10 : Global Market Shares for DTC Testing, by Distribution Channel, 2023
  • Figure 11 : Global Market Shares for DTC Testing, by Region, 2023
  • Figure 12 : North American Market for DTC Testing, 2021-2029
  • Figure 13 : European Market for DTC Testing, 2021-2029
  • Figure 14 : Asia-Pacific Market for DTC Testing, 2021-2029
  • Figure 15 : Rest of the World Market for DTC Testing, 2021-2029
  • Figure 16 : DTC: Market Player Share Analysis, 2023
  • Figure 17 : DTC Testing: Recent Developments, by Category, 2024
  • Figure 18 : ESG Pillars
  • Figure 19 : Advantages of ESG for Companies
  • Figure 20 : ESG Penetration, DTC Testing Market, 2024
  • Figure 21 : Methodology Used in Direct-to-Consumer Testing Market
  • Figure 22 : 23andMe Inc.: Revenue Shares, by Business Unit, FY 2023
  • Figure 23 : 23andMe Inc.: Revenue Shares, by Country/Region, FY 2023
  • Figure 24 : Genetic Technologies Ltd.: Revenue Shares, by Business Unit, FY 2023
  • Figure 25 : Genetic Technologies Ltd.: Revenue Shares, by Country/Region, FY 2023
  • Figure 26 : Laboratory Corporation of America Holdings: Revenue Shares, by Business Unit, FY 2023
  • Figure 27 : Quest Diagnostics Inc.: Revenue Shares, by Business Unit, FY 2023